ETF Managers Group’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q3 | – | Sell |
-18,833
| Closed | -$1.58M | – | 715 |
|
2022
Q2 | $1.58M | Buy |
+18,833
| New | +$1.58M | 0.05% | 185 |
|
2018
Q2 | – | Sell |
-801
| Closed | -$62K | – | 499 |
|
2018
Q1 | $62K | Buy |
801
+100
| +14% | +$7.74K | ﹤0.01% | 490 |
|
2017
Q4 | $64K | Buy |
701
+100
| +17% | +$9.13K | ﹤0.01% | 439 |
|
2017
Q3 | $56K | Buy |
601
+56
| +10% | +$5.22K | ﹤0.01% | 315 |
|
2017
Q2 | $50K | Buy |
+545
| New | +$50K | ﹤0.01% | 364 |
|
2016
Q1 | $27K | Buy |
+307
| New | +$27K | 0.02% | 385 |
|